Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Another Try at break 2$ USD

<< Previous

Bullboard Posts

Next >>

Post by SundayMovieson Dec 20, 2022 3:49pm

204 Views

Post# 35183057

Another Try at break 2$ USD

The 2$ USD ceiling is a psychological barrier but also an algorithm key level we want to break once an for all.

I think we pass this mark. If so, much more upside ahead.
So, please new investors and traders, you are most welcome here.

Deploy your cash here. Let's move the share price higher and make some $$$$

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing